1. Home

Drugs

The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States

Topic Paragraphs
A smiling woman is applying sunscreen to a young child's face. They are outdoors in a grassy park on a sunny day. The woman is wearing a blue sun hat and sunglasses, and the child is wearing a yellow cap.

New ingredient added for use in sunscreen formulas

The FDA has added bemotrizinol as an active ingredient for use in sunscreens, supporting greater consumer choice for safe and effective sun protection products.

Read more about this new ingredient
Consumer Contact Information Drug Alerts and Statements What's New Related to Drugs

Search our databases:

Drugs@FDA

Find information about most FDA-approved prescription, generic, and over-the-counter drug products.

Drug Shortages

Find information about drug shortages caused by manufacturing and quality problems, delays, and discontinuations.

Orange Book

The Orange Book identifies drug products approved by FDA on the basis of safety and effectiveness.

News

A female doctor in a white coat examines a young female patient's ankle as the child sits on an examination table.

Experts gather to accelerate therapy options for childhood lupus

The upcoming meeting addresses clinical trial challenges for young patients
A scientist in a lab coat uses a digital tablet to analyze a colorful 3D cellular model while collaborating with a colleague.

Digital testing concept moves forward to help evaluate drug safety

This innovative approach is a new way to help predict liver damage
Graphic with the words 'New Drug Approval' above a line drawing of different medication types, including a vial, nasal spray, pill bottle, patch, and syringe.

Two-drug approach advances care for early-stage bladder cancer

Combined therapy protects underlying tissue and stops the disease from spreading

Navigate the Drugs Section

Center

Upcoming Drug-related Events

Priority Areas & Initiatives

Opioids

Reducing the impact of opioid misuse and abuse

Generics

Ensuring access to safe, affordable, and effective generic drugs

Warning Letters

Warning and Notice of Violation Letters to Pharmaceutical Companies

Guidances

FDA's current thinking on drug development and review activities

Drug Shortages

Search the database, learn about root causes and potential solutions

Resources

Information for consumers, health professionals, and industry

Contact Us

Division of Drug Information
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Building 51, Room 1109
Silver Spring, MD 20993

druginfo@fda.hhs.gov

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

Center for Drug Evaluation and Research (CDER)

Paragraph Header (Column 2)
FOR UPDATES ON X FOLLOW

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.

Back to Top